[Molecular mechanisms in myeloproliferative diseases and myelodysplastic syndromes].

Abstract excerpt

Little was known about the mechanisms for myeloproliferative diseases (MPD) until 2005 when an activating mutation in the JAK2 tyrosine kinase (JAK2 V617F) was identified in >95% of patients with polycythemia vera (PV), and in a significant proportion of patients with essential thormbocythemia (E...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Core Binding Factor Alpha 2 Subunit
• Share to JAK2 gene
• Share to RUNX1 gene